CE: An Evidence-Based Update on Contraception

Abstract

Recommendations and Reports Disclosure of Relationship CDC, our planners, and our content experts wish to disclose they have no financial interest or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias. This document will not include any discussion of the unlabeled use of a product or a product under investigational use, with the exception that some of the recommendations in this document might be inconsistent with package labeling.

Multipurpose Prevention Technologies: Opportunities and Challenges to Ensure Advancement of the Most Promising MPTs

“…The current MPT field is building upon lessons learned from decades of research in contraception, HIV topical microbicide development, systemic HIV prevention products and prevention of non-HIV STIs. A number of single indication contraceptive products are available to women (23)(24)(25) and new innovations are also underway for male contraception (25,26). Single indication HIV-only prevention products are also in development.…”

Iron-Containing Oral Contraceptives and Their Effect on Hemoglobin and Biomarkers of Iron Status: A Narrative Review

“…Contraceptives can be categorized into two methods: hormonal and non-hormonal contraception. The former includes contraception methods, such as hormonal intrauterine devices (IUD), oral contraceptive pills, and the vaginal ring [ 3 ]. The latter consists of barrier methods (male or female condom, with or without spermicide), copper IUD, the withdrawal method [ 3 ], and fertility awareness-based methods (FAM) [ 4 ], characterized by observing the physical signs that change throughout the different phases of a woman’s menstrual cycle along with hormone fluctuations to predict and monitor the fertile and infertile days.…”

“…The former includes contraception methods, such as hormonal intrauterine devices (IUD), oral contraceptive pills, and the vaginal ring [ 3 ]. The latter consists of barrier methods (male or female condom, with or without spermicide), copper IUD, the withdrawal method [ 3 ], and fertility awareness-based methods (FAM) [ 4 ], characterized by observing the physical signs that change throughout the different phases of a woman’s menstrual cycle along with hormone fluctuations to predict and monitor the fertile and infertile days. The importance of universal access to family planning education and services is underscored by the global commitment made in the Sustainable Development Goal target 3.7.1—that by 2030, access to sexual and reproductive healthcare services could be ensured to all, and that reproductive health be integrated into national strategies and programs [ 5 ].…”

Os anticoncepcionais orais como fator de risco cardiovascular: uma revisão narrativa

“…Em 2015, foram atualizados os critérios de elegibilidade dos anticoncepcionais de alta efetividade, definindo recomendações que relacionam critérios de saúde da mulher e o uso de anticoncepcionais reversíveis. O problema surge quando o tratamento não é individualizado para cada mulher de maneira que o torna como fator de risco cardiovascularacidente vascular encefálico (AVE), infarto, trombose -, posto que os hormônios presentes nesse tipo de medicação potencializam quadros de vasoconstrição sanguínea, além de corroborar uma formação de coágulos de forma mais rápida, fato que prejudica a circulação sanguínea a nível (BRITTON LE, et al, 2020).…”

“…Universidade do Grande Rio (Unigranrio), Rio de Janeiro -RJ 4. Centro Universitário do Estado do Pará (CESUPA), Belém -PA 5.…”